Loading...
Loading...
Lannett Company, Inc.
LCI today announced that it has received
approval from the U.S. Food and Drug Administration (FDA) of its supplemental
Abbreviated New Drug Application (ANDA) for Phentermine HCl Capsules, 15 mg.
Sales of Phentermine HCl Capsules, 15 mg, at Average Wholesale Price (
AWP)
were approximately $11 million for the year ending December 2011, according to
Wolters Kluwer. Additional sales of this drug are made through bariatric
centers. The company expects to commence shipping the product shortly.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in